Based on a multivariate analysis model including adjuvant therapy and tumor grade in NMIBC, RFS was associated with HER2+, while OS was associated with age, T-stage, EP263, PD1, CD8, and Ki67 levels. Here, MKI67 is linked to neoplasm.